NEOGENOMICS INC — Director's Dealing 2016

Aug 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-08-19

Reporting Person: ALBITAR MAHER (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-19	Common Stock	M	200000	$1.43	Acquired	263492	Direct
2016-08-19	Common Stock	M	20000	$3.45	Acquired	283492	Direct
2016-08-19	Common Stock	M	100000	$4.78	Acquired	383492	Direct
2016-08-19	Common Stock	M	250000	$1.43	Acquired	633492	Direct
2016-08-19	Common Stock	S	370000	$8.23	Disposed	263492	Direct
2016-08-19	Common Stock	F	34625	$8.26	Disposed	228867	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-19	Warrants (Right to Buy)	$1.43	X	200000	Disposed	2017-01-09	Common Stock (200000)	Direct
2016-08-19	Stock Option (Right to Buy)	$3.45	X	20000	Disposed	2019-03-05	Common Stock (20000)	Direct
2016-08-19	Stock Option (Right to Buy)	$4.78	X	100000	Disposed	2020-05-05	Common Stock (100000)	Direct
2016-08-19	Stock Option (Right to Buy)	$1.43	X	250000	Disposed	2017-01-09	Common Stock (250000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	63492	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000)	200000	Direct

Footnotes

F1: Shares withheld by NeoGenomics, Inc. to satisfy the cost of shares in connection with the August 19, 2016 warrant exercise.

F2: Closing stock price on date of exercise, August 19, 2016.

F3: These warrants were issued to Dr. Albitar upon the start of his service to the Company and vest upon the achievement of certain milestones.

F4: On March 5, 2014 Dr. Albitar was granted 30,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On May 5, 2015 Dr. Albitar was granted 300,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F6: These stock options were granted upon the start of Dr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.

F7: On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.